An update on anti-cholinergic burden for pharmacy researchers and practitioners
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: HMI-030
- By: MAIDMENT, Ian (Aston University, United Kingdom)
- Co-author(s): Dr Ian Maidment, Reader In Clinical Pharmacy (Aston University, Birmingham, United Kingdom)
Professor Chris Fox, Department of Psychiatry (Exeter University, Exeter, United Kindom)
Dr Kathryn Richardson, Medical School (UEA, Norwich, United Kingdom)
Dr Frank Moriarty, School of Pharmacy and Biomolecular Sciences (RCSI School of Pharmacy and Biomolecular Sciences, Dublin, Ireland)
Professor Phyo Mynt, Medical School (Aberdeen Univerity, Aberdeen, United Kingdom)
Many medicines possess anti-cholinergic activity and are associated with adverse events such as confusion, tachycardia, blurred vision and constipation. There is increasing evidence that medicines with significant anti-cholinergic activity are particularly damaging in older people at risk of dementia.
It is vital that.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.